Sanochemia Pharmazeutika Ag Names Timo Bender as CEO, Effective February 1, 2019

Sanochemia Pharmazeutika AG is an Austrian pharmaceutical company focused on the development and manufacture of drugs and diagnostics in neurodegeneration, pain and oncology areas, among others, as well as diagnostics based on contrast media. It operates through three main business divisions and the Production Division, which acts on behalf of those business divisions or on a contract manufacturing basis. The Production Division is engaged in the synthesis of active pharmaceutical substances (APIs), drug formulation and pharmaceutical production. The Human Pharmaceuticals Division is primarily responsible for the Company's diagnostic activities. The Research and Development Division is responsible for the Company's development activities. The Veterinary Pharmaceuticals Division comprises a portfolio of veterinary medical product and distribution channels in the CEE markets, Middle East and South-East Asia. The Company's shareholders are Inphasearch AG and Invesa AG, among others.